Corporate Headquarters
420 Stevens Avenue
Suite 370
Solana Beach, CA 92075

(858)345-1494 Tel.

Investor Relations :: Press Releases

All Releases
View Summary Evoke Pharma Announces Pricing of Public Offering of Common Stock
Feb 16, 2017
PDF 11.1 KB
View Summary Evoke Pharma Announces Proposed Public Offering of Common Stock
Feb 15, 2017
PDF 11.2 KB
View Summary FDA Exempts Evoke from Requirement for Human Factor Validation Study
Feb 15, 2017
PDF 11.3 KB
View Summary Evoke Pharma to Attend 2017 JPMorgan Healthcare Conference
Jan 9, 2017
PDF 10.7 KB
View Summary Evoke Provides Additional Data Demonstrating Statistically Significant Benefit for Gimoti in Moderate to Severe Patients in Phase 3 Diabetic Gastroparesis Trial
Jan 4, 2017
PDF 18.6 KB
View Summary Evoke Receives Positive NDA Submission Guidance from US FDA for Gimoti
Dec 15, 2016
PDF 11.8 KB
View Summary Evoke Pharma Reports Third Quarter 2016 Results
Nov 9, 2016
PDF 20.2 KB
View Summary Evoke Pharma Schedules Webcast and Conference Call for Third Quarter 2016 Financial Results
Nov 1, 2016
PDF 8.8 KB
View Summary Evoke Pharma Announces Positive Non-Clinical Pre-NDA Meeting with FDA for Gimoti
Sep 7, 2016
PDF 12.5 KB
View Summary Evoke Pharma to Present at Rodman & Renshaw 18th Annual Global Investment Conference
Sep 6, 2016
PDF 9.0 KB
View Summary Evoke Pharma Reports Second Quarter 2016 Results
Aug 15, 2016
PDF 19.8 KB
View Summary Evoke Pharma Schedules Webcast and Conference Call for Second Quarter 2016 Financial Results
Aug 10, 2016
PDF 8.8 KB
View Summary Evoke Pharma Completes Credit Facility Repayment
Aug 8, 2016
PDF 10.3 KB
View Summary Evoke Pharma Announces $10 Million Registered Direct Offering Priced At-The-Market
Jul 29, 2016
PDF 11.6 KB
View Summary Evoke Pharma Receives Conditional FDA Acceptance of Proposed Brand Name for EVK-001
Jul 26, 2016
PDF 10.7 KB
View Summary Evoke Pharma Announces $4.5 Million At-The-Market Offering
Jul 20, 2016
PDF 11.3 KB
View Summary Evoke Pharma Reports Topline Results from EVK-001 Phase 3 Clinical Trial
Jul 18, 2016
PDF 13.2 KB
View Summary Evoke Advances Commercial Preparations for EVK-001 with inVentiv Agreement
Jul 7, 2016
PDF 11.6 KB
View Summary Evoke Advances Commercial Preparations for EVK-001 with inVentiv Agreement
Jul 7, 2016
PDF 12.5 KB
View Summary Evoke Completes Phase 3 Clinical Trial of EVK-001 in Women with Symptoms Associated with Diabetic Gastroparesis
Jun 1, 2016
PDF 12.4 KB
Showing 1-20 of 79 Page: 1 2 3 4  Next 20